Abdominal Stent Graft System Market to Reach USD 2.7 Billion by 2034, Growing from USD 1.6 Billion in 2025 - SRI

London, UK - August 2026 | Strategic Revenue Insights Inc. - Regulatory clarity is finally arriving for makers of implantable vascular devices, though it comes with conditions attached. Under the European Union's medical device framework, transitional conformity deadlines were staggered by risk class, giving higher-risk implantable devices until the end of 2027 and medium and lower-risk devices until the end of 2028 to complete assessment, provided manufacturers have already applied for certification with a designated notified body, according to the European Commission. Against that backdrop, the abdominal stent graft system market was valued at USD 1.6 billion in 2025 and is projected to reach USD 2.7 billion by 2034, growing at a CAGR of 6.00% during the forecast period, according to a new report from Strategic Revenue Insights Inc. The findings are led by lead analyst Anirudh Singh, whose research draws on primary interviews with vascular surgeons, hospital procurement teams, and device manufacturers, combined with secondary data spanning Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.

Key Takeaways

• The market was valued at USD 1.6 billion in 2025 and is forecast to reach USD 2.7 billion by 2034, a CAGR of 6.00%.
• Bifurcated Stent Grafts are the largest product type, while Fenestrated & Branched Grafts is the fastest-growing category on their ability to treat complex aneurysms.
• Digital technologies such as 3D printing and AI-driven imaging are enabling more personalized, precisely fitted stent graft designs.
• North America leads the market on advanced healthcare infrastructure and high vascular disease prevalence, while Asia Pacific is the fastest-growing region.
• Medtronic, W. L. Gore & Associates, and Cook Medical are among the leading companies shaping the competitive landscape.

Full report access: https://www.strategicrevenueinsights.com/industry/abdominal-stent-graft-system-market

Aging Populations and a Push Toward Precision Repair

The primary force behind the market's growth is demographic: the rising prevalence of abdominal aortic aneurysms and related vascular conditions among an aging population is driving demand for effective, less invasive treatment options. As more patients and providers move away from traditional open surgery, stent graft systems have become the preferred route, a shift reinforced by favorable reimbursement policies and continued improvements in device materials and design that boost both safety and efficacy.

Personalization is reshaping how these devices get made. Growing focus on patient-centric care is fueling demand for stent grafts tailored to individual patient anatomies, and manufacturers are increasingly turning to digital tools such as 3D printing and AI-driven imaging to design and produce devices with greater precision. That shift toward customization is also feeding a broader move toward automation in manufacturing, as companies look to scale output while meeting patient-specific specifications.

Care settings are shifting too. The growing emphasis on outpatient procedures and the expansion of ambulatory surgical centers is increasing demand for stent graft systems that support quicker recovery and shorter hospital stays, while some manufacturers are also localizing production to reduce supply chain disruption and keep pace with regional demand.

Market Segmentation

By Product Type: Bifurcated Stent Grafts hold the largest share thanks to their widespread use in treating abdominal aortic aneurysms, while Fenestrated & Branched Grafts are the fastest-growing category for their ability to treat complex aneurysms, alongside Aorto-Uni-Iliac Grafts and Tube Grafts.

By Material: Polyester (PET) is a leading choice for its durability and flexibility, while Nitinol Frames are gaining popularity for their shape memory properties that ease deployment, alongside ePTFE and Stainless Steel Frames.

By Deployment: Balloon-Expandable systems are preferred for their precision and control in complex procedures, while Self-Expanding systems are gaining popularity for their ease of use and ability to conform to patient anatomy without extra equipment.

By Indication: Abdominal Aortic Aneurysm is the most common indication driving demand, with Iliac Artery Aneurysm and Aortic Dissection also representing significant and growing procedure volumes, alongside Traumatic Injury.

By End Use: Hospitals are the largest end-use segment given their infrastructure for complex surgeries, while Ambulatory Surgical Centers are the fastest-growing setting as outpatient procedures expand, alongside Cardiac Centers.

Regional Outlook

North America dominates the abdominal stent graft system market, supported by advanced healthcare infrastructure and a high prevalence of vascular diseases. Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure and increasing prevalence of vascular diseases. Europe, Latin America, and Middle East & Africa round out the report's regional coverage as the market continues to expand globally.

Competitive Landscape

Medtronic is a leading player known for advanced stent graft systems that deliver strong performance and patient outcomes, backed by a sustained commitment to innovation. W. L. Gore & Associates is recognized for high-quality stent graft systems built to meet stringent healthcare provider requirements, while Cook Medical offers a wide range of systems addressing multiple indications and patient needs. Terumo Aortic is known for a comprehensive portfolio addressing complex vascular conditions, and Endologix, Cordis, Braile Biomedica, MicroPort, and Lifetech Scientific round out a competitive field where research and development investment and quality assurance remain key differentiators.

Market Restraints

Regulatory compliance remains the market's most significant headwind. Under the EU's staggered conformity assessment timeline, companies face sustained spending on regulatory and clinical evidence obligations even as deadlines extend into 2027 and 2028, and post-market clinical follow-up requirements remain fully in force regardless of the timeline extension. Compounding this, the high cost of stent graft systems and limited reimbursement coverage in certain regions can make healthcare providers hesitant to adopt these more expensive treatment solutions.

Related Reports

https://www.strategicrevenueinsights.com/industry/two-wheeler-fuel-injection-system-market

https://www.strategicrevenueinsights.com/industry/electric-commercial-vehicle-traction-motor-market

https://www.strategicrevenueinsights.com/industry/wireless-charging-for-electric-vehicles-market

https://www.strategicrevenueinsights.com/industry/regenerative-braking-system-market

https://www.strategicrevenueinsights.com/industry/luxury-electric-vehicle-market

Frequently Asked Questions

How big is the abdominal stent graft system market?

The market was valued at USD 1.6 billion in 2025 and is projected to reach USD 2.7 billion by 2034, growing at a CAGR of 6.00%.

What is driving growth in the abdominal stent graft system market?

Growth is driven by the increasing prevalence of abdominal aortic aneurysms and other vascular diseases in an aging population, along with rising adoption of minimally invasive procedures.

Which region leads the abdominal stent graft system market?

North America leads the market on advanced healthcare infrastructure and high vascular disease prevalence, while Asia Pacific is the fastest-growing region.

Who are the key companies in the abdominal stent graft system market?

Leading companies include Medtronic, W. L. Gore & Associates, and Cook Medical, along with Terumo Aortic, Endologix, Cordis, Braile Biomedica, MicroPort, and Lifetech Scientific.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases